Australia appears to be experience potentially transformative medication for weight issues: Retatrutide. This new dual molecule – working on both GLP-1 and GIP receptors – has significant outcomes in clinical research, suggesting considerable drops in body fat. While regulatory clearance is pending with the Therapeutic Goods Administration (TGA… Read More